Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.6800
+0.0300 (4.62%)
At close: Aug 6, 2026
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 46.73 million as of August 7, 2026. Its market cap has decreased by -15.50% in one year.
Market Cap
46.73M
Enterprise Value
35.49M
Revenue
21.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.68
ChartMarket Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 46.73M, a decrease of -80.15%. That is a compound annual growth rate of -28.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 46.73M | 5.52% |
| Dec 30, 2025 | 44.29M | 81.07% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Redsense Medical AB | 66.77M |
| Mendole | 59.00M |
| Touchtech AB | 55.43M |
| Kontigo Care AB | 53.93M |
| OurLiving AB | 44.98M |
| Lightning Group AB | 40.44M |
| Aerowash AB | 38.92M |
| Gomero Group AB | 36.46M |